Stock Market News
Roche's Avastin misses prostate cancer goal
12-03-2010 10:00
| Add To Google +1 | Tweet |
Roche is the top faller on the Swiss market after the pharma giant's best-selling cancer drug Avastin did not meet its primary objective in a late-stage prostate cancer trial.
The group said the results of a phase III trial showed that the drug failed its primary objective of extending overall survival compared to chemotherapy and prednisone alone.
"It is unfortunate that the study did not meet its primary objective, however, we look forward to sharing the data with the medical community, including the secondary endpoints," said Hal Barron, M.D., Head Global Development and Chief Medical Officer at Roche.
The firm said Avastin's development programme in other tumour types will continue as planned.
The group said the results of a phase III trial showed that the drug failed its primary objective of extending overall survival compared to chemotherapy and prednisone alone.
"It is unfortunate that the study did not meet its primary objective, however, we look forward to sharing the data with the medical community, including the secondary endpoints," said Hal Barron, M.D., Head Global Development and Chief Medical Officer at Roche.
The firm said Avastin's development programme in other tumour types will continue as planned.
| Related share prices |
|---|
Stock News is provided by Digital Look Corporate Solutions from Sharecast news. Please read the terms and conditions of useage of this data. Republication or redistribution of content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd.
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- UK 100 Shares
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways share price
- Centrica share price
- Tesco share price
- National Grid share price
- RBS share price
- GSK share price
- Marks and Spencer
- Rolls Royce share price
- Banco Santander price
- Rio Tinto share price
- Amec Share price
- Corac share price
- Lookers share price
- Telecom plus share price
- Kier share price
- Punch taverns price
- Blinkx share price
- Tan share price
- Yell share price
- Rsa share price
- Pendragon share price
- Logica share price
- Bat share price
- Sky share price
- Kingfisher share price
- Dragon Oil share price
- Desire Petroleum share price
- RRL share price
- BPC share price
- VOG share price
- SAR share price


Prices

